US6818629B2
(en)
|
1997-02-10 |
2004-11-16 |
Inspire Pharmaceuticals, Inc. |
Pharmaceutical formulation comprising P1-(2'-deoxycytidine 5'-)P4-(uridine 5'-) tetraphosphate
|
US6596725B2
(en)
*
|
1997-02-10 |
2003-07-22 |
Inspire Pharmaceuticals, Inc. |
Use of certain dinucleotides to stimulate removal of fluid in retinal detachment and retinal edema
|
US7223744B2
(en)
*
|
1997-02-10 |
2007-05-29 |
Inspire Pharmaceuticals, Inc. |
Pharmaceutical formulation comprising dinucleoside polyphosphates and salts thereof
|
US7078391B2
(en)
*
|
1997-02-10 |
2006-07-18 |
Inspire Pharmaceuticals, Inc. |
Method of treating edematous retinal disorders
|
US6455554B1
(en)
*
|
1999-06-07 |
2002-09-24 |
Targacept, Inc. |
Oxopyridinyl pharmaceutical compositions and methods for use
|
US6576224B1
(en)
*
|
1999-07-06 |
2003-06-10 |
Sinuspharma, Inc. |
Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
|
US20020061281A1
(en)
*
|
1999-07-06 |
2002-05-23 |
Osbakken Robert S. |
Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
|
ES2425114T3
(es)
*
|
2000-03-16 |
2013-10-11 |
The Mclean Hospital Corporation |
CDP-colina y uridina para el tratamiento del abuso del acohol
|
CA2359813C
(en)
*
|
2000-10-24 |
2008-04-22 |
Richard L. Jones |
Nicotine mucosal spray
|
GB2381750A
(en)
*
|
2001-10-10 |
2003-05-14 |
Inspire Pharmaceuticals Inc |
Treatment for enhancing joint lubrication
|
US6852741B2
(en)
|
2001-12-31 |
2005-02-08 |
University Of Florida |
Compositions and methods for treatment of neurological disorders
|
US6659985B2
(en)
|
2002-01-30 |
2003-12-09 |
Southern College Of Optometry |
Method to use transdermal administration of androgens to the adnexa of the eye
|
US7069084B2
(en)
*
|
2002-06-14 |
2006-06-27 |
Seefit Incorporated |
Method and apparatus for preventing and treating eyelid problems
|
EP1539152A4
(de)
*
|
2002-08-02 |
2006-10-18 |
Nutraceutical Dev Corp |
ENTWICKLUNG DER MUSKELMASSE IN EINEM SûUGETIER
|
US7179481B2
(en)
*
|
2002-09-19 |
2007-02-20 |
Kimberly-Clark Worldwide, Inc. |
Vaginal health products
|
CN1700894A
(zh)
*
|
2002-10-18 |
2005-11-23 |
莫利化学医药公司 |
使用羊毛硫抗生素治疗干眼病的方法
|
UA83011C2
(ru)
*
|
2002-11-08 |
2008-06-10 |
Зе Маклин Хоспитал Корпорейшн |
Соединения для лечения табачной зависимости и синдрома отмены
|
US7098189B2
(en)
*
|
2002-12-16 |
2006-08-29 |
Kimberly-Clark Worldwide, Inc. |
Wound and skin care compositions
|
US7056889B2
(en)
|
2002-12-16 |
2006-06-06 |
Kimberly-Clark, Worldwide, Inc. |
Compounds that bind P2Y2 or P2Y1 receptors
|
JP4717444B2
(ja)
*
|
2002-12-20 |
2011-07-06 |
ザ マクレーン ホスピタル コーポレーション |
睡眠/覚醒サイクルの正規化のための化合物
|
KR20120035220A
(ko)
*
|
2003-01-22 |
2012-04-13 |
센주 세이야꾸 가부시키가이샤 |
안질환 치료용 경피 흡수형 제제, 그 사용, 및 안질환 치료약의 눈의 국소 조직으로의 이행 방법
|
US20050013806A1
(en)
*
|
2003-04-04 |
2005-01-20 |
Chang Min S. |
Use of contact lens for corneal cell transplant
|
US20050208102A1
(en)
*
|
2003-04-09 |
2005-09-22 |
Schultz Clyde L |
Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases
|
US20050255144A1
(en)
*
|
2003-04-09 |
2005-11-17 |
Directcontact Llc |
Methods and articles for the delivery of medicaments to the eye for the treatment of posterior segment diseases
|
US9216106B2
(en)
*
|
2003-04-09 |
2015-12-22 |
Directcontact Llc |
Device and method for the delivery of drugs for the treatment of posterior segment disease
|
US20050074497A1
(en)
*
|
2003-04-09 |
2005-04-07 |
Schultz Clyde L. |
Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases
|
US6984628B2
(en)
*
|
2003-07-15 |
2006-01-10 |
Allergan, Inc. |
Ophthalmic compositions comprising trefoil factor family peptides
|
EP1727554A4
(de)
*
|
2003-10-08 |
2009-09-30 |
Mclean Hospital Corp |
Verfahren zur behandlung von psychiatrischen erkrankungen, substanzmissbrauch und anderen erkrankungen unter verwendung von kombinationen mit omega-3-fettsäuren
|
WO2005034874A2
(en)
*
|
2003-10-08 |
2005-04-21 |
The Mclean Hospital Corporation |
Enhanced efficacy of omega-3 fatty acid therapy in the treatment of psychiatric disorders and other indications
|
WO2005060984A1
(en)
*
|
2003-12-12 |
2005-07-07 |
Yee Richard W |
Method and apparatus for preventing and treating eyelid problems
|
US20060270592A1
(en)
*
|
2004-03-19 |
2006-11-30 |
Ophthalmic Research Associates, Inc. |
Use of neurotransmitters and neuropeptides for the treatment of dry eye diseases and related conditions
|
EP1753445A4
(de)
*
|
2004-05-06 |
2009-05-20 |
Molichem Medicines Inc |
Behandlung von augenerkrankungen und augenleiden mit lantibiotischen zusammensetzungen
|
EP1750740A4
(de)
*
|
2004-05-06 |
2009-06-10 |
Molichem Medicines Inc |
Behandlung von membran-bedingten erkrankungen und störungen unter verwendung von lantibiotikum enthaltenden zusammensetzungen
|
DE602005019724D1
(de)
*
|
2004-05-21 |
2010-04-15 |
Senju Pharma Co |
Ophthalmologische perkutan absorbierbare zubereitung enthaltend einen muscarin-rezeptor-agonist
|
EP1752456B1
(de)
*
|
2004-06-03 |
2015-08-26 |
Senju Pharmaceutical Co., Ltd. |
Eine Amidverbindung enthaltendes Arzneimittel zur Wiederherstellung des Sehvermögens der Hornhaut
|
WO2005123097A1
(en)
*
|
2004-06-10 |
2005-12-29 |
Mclean Hospital Corporation |
Pyrimidines, such as cytidine, in treatments for patients with bipolar disorder
|
EP1765075A4
(de)
*
|
2004-06-10 |
2010-11-10 |
Mclean Hospital Corp |
Pyrimidine, wie z.b. uridin; bei der behandlung von patienten mit manisch-depressiver psychose
|
US7485666B2
(en)
*
|
2004-06-17 |
2009-02-03 |
Kimberly-Clark Worldwide, Inc. |
Vaginal health products
|
EP1784199A4
(de)
*
|
2004-08-11 |
2010-06-23 |
Mclean Hospital Corp |
Verbindungen zur behandlung von marihuana-abhängigkeit, entzug und konsum
|
US20080233053A1
(en)
*
|
2005-02-07 |
2008-09-25 |
Pharmalight Inc. |
Method and Device for Ophthalmic Administration of Active Pharmaceutical Ingredients
|
JPWO2007013661A1
(ja)
*
|
2005-07-26 |
2009-02-12 |
千寿製薬株式会社 |
眼科用経皮吸収型製剤
|
FR2889847B1
(fr)
|
2005-08-18 |
2007-10-05 |
Sanofi Aventis Sa |
Derives de 5-pyridazinyl-1-azabicyclo[3.2.1]octave, leur preparation en therapeutique.
|
AU2006294581B2
(en)
|
2005-09-27 |
2011-11-03 |
Tissuetech, Inc. |
Amniotic membrane preparations and purified compositions and methods of use
|
US8187639B2
(en)
|
2005-09-27 |
2012-05-29 |
Tissue Tech, Inc. |
Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
|
JP6088723B2
(ja)
|
2005-11-23 |
2017-03-01 |
ジェネンテック, インコーポレイテッド |
B細胞アッセイに関する組成物及び方法。
|
US20070231360A1
(en)
*
|
2006-03-28 |
2007-10-04 |
Minu, L.L.C. |
Neural conduit agent dissemination
|
US20070237797A1
(en)
*
|
2006-03-28 |
2007-10-11 |
Gholam A. Peyman |
Neural Conduit Agent Dissemination
|
US20070297991A1
(en)
*
|
2006-06-23 |
2007-12-27 |
Minu, L.L.C. |
Neural conduit agent dissemination for smoking cessation and other applications
|
US20080107713A1
(en)
*
|
2006-11-08 |
2008-05-08 |
Orilla Werhner C |
Contact lens as a sustained drug delivery implant
|
US20080317819A1
(en)
*
|
2007-06-21 |
2008-12-25 |
Orilla Werhner C |
Iop lowering drug combination or non-combination loaded contact lens with zonal drug delivery areas
|
US20090004244A1
(en)
*
|
2007-06-27 |
2009-01-01 |
Orilla Werhner C |
Iris design as a drug depot for zonal drug delivery by contact lens
|
US20090004245A1
(en)
*
|
2007-06-28 |
2009-01-01 |
Orilla Werhner C |
Use of an iris simulated layer to allow aesthetic appearance drug loaded contact lens
|
DE102007055046A1
(de)
*
|
2007-11-19 |
2009-05-28 |
Fluoron Gmbh |
Infusionslösung
|
GB0724558D0
(en)
*
|
2007-12-15 |
2008-01-30 |
Sharma Anant |
Optical correction
|
US20110217387A1
(en)
*
|
2008-05-16 |
2011-09-08 |
Axis, Inc. |
Pharmaceutical composition for treatment of fibromyalgia
|
US20100041621A1
(en)
*
|
2008-08-15 |
2010-02-18 |
Perry Renshaw |
Methods and compositions for improving cognitive performance
|
WO2010045212A2
(en)
*
|
2008-10-14 |
2010-04-22 |
Psychogenics, Incstatuts |
Nicotinic acetylcholine receptor ligands and the uses thereof
|
AU2010213244A1
(en)
*
|
2009-02-11 |
2010-08-19 |
Heglund, A.S. |
A composition for buccal absorption of nicotine for the purpose of smoking cessation
|
TWI578997B
(zh)
|
2010-06-04 |
2017-04-21 |
輝瑞疫苗有限責任公司 |
用於預防或治療菸鹼成癮之共軛體
|
CA2817589A1
(en)
|
2010-11-16 |
2012-05-24 |
The Board Of Trustees Of The Leland Stanford Junior University |
Systems and methods for treatment of dry eye
|
US9821159B2
(en)
|
2010-11-16 |
2017-11-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
Stimulation devices and methods
|
EP3513787A1
(de)
*
|
2011-01-10 |
2019-07-24 |
Invion, Inc |
Verwendung von beta-adrenergen inversen agonisten zur raucherentwöhnung
|
ES2822301T3
(es)
|
2011-06-10 |
2021-04-30 |
Tissuetech Inc |
Métodos de procesamiento de tejidos de soporte fetal
|
WO2013032938A1
(en)
|
2011-08-26 |
2013-03-07 |
Tissuetech, Inc. |
Methods of sterilizing fetal support tissues
|
US9132193B2
(en)
*
|
2012-11-05 |
2015-09-15 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Use of Slurp1 as an imunomodulatory molecule in the ocular surface
|
RU2510701C1
(ru)
*
|
2012-12-19 |
2014-04-10 |
Федеральное государственное бюджетное учреждение "Научно-исследовательский институт глазных болезней" Российской академии медицинских наук (ФГБУ "НИИГБ" РАМН) |
Способ лечения блефароконъюнктивальной формы синдрома сухого глаза
|
US9265956B2
(en)
|
2013-03-08 |
2016-02-23 |
Oculeve, Inc. |
Devices and methods for treating dry eye in animals
|
WO2014165124A1
(en)
|
2013-03-12 |
2014-10-09 |
Oculeve, Inc. |
Implant delivery devices, systems, and methods
|
NZ704579A
(en)
|
2013-04-19 |
2018-10-26 |
Oculeve Inc |
Nasal stimulation devices and methods
|
WO2015130707A2
(en)
|
2014-02-25 |
2015-09-03 |
Oculeve, Inc. |
Polymer formulations for nasolacrimal stimulation
|
US9303013B2
(en)
|
2014-05-16 |
2016-04-05 |
Pfizer Inc. |
Conjugates and associated methods of producing them for the prevention or treatment of nicotine addiction
|
WO2016015025A1
(en)
|
2014-07-25 |
2016-01-28 |
Oculeve, Inc. |
Stimulation patterns for treating dry eye
|
SG10202011669PA
(en)
|
2014-10-20 |
2020-12-30 |
Oyster Point Pharma Inc |
Methods of treating ocular conditions
|
EP3209371A4
(de)
|
2014-10-22 |
2018-10-24 |
Oculeve, Inc. |
Implantierbare nasenstimulatorsysteme und verfahren
|
WO2016065215A1
(en)
|
2014-10-22 |
2016-04-28 |
Oculeve, Inc. |
Stimulation devices and methods for treating dry eye
|
CA2965514A1
(en)
|
2014-10-22 |
2016-04-28 |
Oculeve, Inc. |
Contact lens for increasing tear production
|
CA2964163A1
(en)
*
|
2014-11-05 |
2016-05-12 |
Tissuetech, Inc. |
Compositions and method for promoting nerve growth and regeneration
|
CN113208809A
(zh)
|
2014-12-31 |
2021-08-06 |
迈克罗欧普提克斯股份有限公司 |
青光眼治疗装置和方法
|
CA2985013C
(fr)
*
|
2015-05-21 |
2024-04-16 |
Ophtalmis Monaco |
Association d'acide lipoique et de taurine en tant qu'agent osmoprotecteur
|
JP2017052723A
(ja)
*
|
2015-09-10 |
2017-03-16 |
株式会社Lttバイオファーマ |
ドライアイ改善剤
|
US10980667B2
(en)
|
2015-09-30 |
2021-04-20 |
Microoptx Inc. |
Eye treatment devices and methods
|
US10426958B2
(en)
|
2015-12-04 |
2019-10-01 |
Oculeve, Inc. |
Intranasal stimulation for enhanced release of ocular mucins and other tear proteins
|
US10252048B2
(en)
|
2016-02-19 |
2019-04-09 |
Oculeve, Inc. |
Nasal stimulation for rhinitis, nasal congestion, and ocular allergies
|
KR102485299B1
(ko)
*
|
2016-04-07 |
2023-01-06 |
오이스터 포인트 파마 인코포레이티드 |
안구 장애의 치료 방법
|
CN109069649A
(zh)
|
2016-04-12 |
2018-12-21 |
A·索利斯·赫雷拉 |
用烟碱乙酰胆碱受体激动剂治疗鼻和鼻旁粘膜病症的组合物和方法
|
CA3022683A1
(en)
|
2016-05-02 |
2017-11-09 |
Oculeve, Inc. |
Intranasal stimulation for treatment of meibomian gland disease and blepharitis
|
KR20190124698A
(ko)
|
2016-12-02 |
2019-11-05 |
오큘레브, 인크. |
건성안 예측 및 치료 권고를 위한 장치 및 방법
|
WO2020014217A1
(en)
*
|
2018-07-10 |
2020-01-16 |
Oyster Point Pharma, Inc. |
Methods of treating ocular conditions
|
TW202317111A
(zh)
*
|
2021-07-07 |
2023-05-01 |
坎培拉大學 |
治療及抑制方法
|